Passage Bio

1 follower

‌

Passage Bio is a genetic medicines company based in Philadelphia, PA that is developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).

Industries

Headquarters

Stage

Employees

Links

Org chart

William Chou
President & CEO

William Chou

Collapse
Simona King
CFO
Alex Fotopoulos
CTO
Mark Forman
Chief Medical Officer
JW
James M. Wilson
Chief Scientific Advisor
Edgar B. Cale
General Counsel & Corporate Secretary
Desiree Luthman
SVP, Global Regulatory Affairs
Jiwen Zhang
VP, Regulatory Affairs
SA
Samiah Al-Zaidy
VP, Clinical Development
KB
Kathleen Borthwick
VP, Financial Planning & Analysis
EF
Eden Fucci
VP, Manufacturing Operations
ZM
Zied Mjaied
VP, Supply Chain & Planning
TV
Tiffini Voss
VP, Clinical Development
SH
Stuart Henderson
VP, Corporate Development & Investor Relations
AC
Andrea Campanile
VP, Clinical Operations
SB
Sue Browne
VP, Biology

Teams

View all

+1

Leadership Team

4 members

CEO and Executive Team

2 members

Board of Directors

0 members

Discover similar companies

Century Therapeutics logo

Century Therapeutics

1 follower

Celularity logo

Celularity

3 followers

SpringWorks Therapeutics logo

SpringWorks Therapeutics

1 follower

Dyne Therapeutics logo

Dyne Therapeutics

1 follower

Sigilon Therapeutics logo

Sigilon Therapeutics

2 followers